Repositioning an endocrine therapeutic within neurology
Repositioning an endocrine therapeutic within neurology
The Client
Multinational pharmaceutical company + path-to-market strategy company
The Need
The Action
Pressure testing product positioning concepts and target product profiles with a range of specialist healthcare professionals across three geographies. The key objective was to elicit deep strategic qualitative insights for the final path-to-market model.
The Outcome
Key differences between markets informed distinct path-to-market strategies for the repositioned drug, appealing to the unmet needs and prescribing drivers across markets.
Principal Consultant
“Thanks to Nicola, key differences between markets were unearthed as part of this project. This informed very different paths to market that will be critical to gaining the attention of healthcare providers and increasing access for patients.”
The client
Multinational pharmaceutical company + path-to-market strategy company
The need
To optimise the neurological benefits of an antidiabetic drug and reposition the drug for a target patient population within the neurological market.
The action
Pressure testing product positioning concepts and target product profiles with a range of specialist healthcare professionals across three geographies. The key objective was to elicit deep strategic qualitative insights for the final path-to-market model.
Key differences between markets informed distinct path-to-market strategies for the repositioned drug, appealing to the unmet needs and prescribing drivers across markets.